Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.61 (
caspase-8
)
6,833
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Indoleamine 2,3-dioxygenase
(
IDO
) is a tryptophan-catabolizing enzyme that, expressed by different cell types, has regulatory effects on T cells resulting from tryptophan depletion in specific local tissue microenvironments. Different mechanisms, however, might contribute to
IDO
-dependent immune regulation. We show here that tryptophan metabolites in the kynurenine pathway, such as 3-hydroxyanthranilic and quinolinic acids, will induce the selective apoptosis in vitro of murine thymocytes and of Th1 but not Th2 cells. T cell apoptosis was observed at relatively low concentrations of kynurenines, did not require Fas/Fas ligand interactions, and was associated with the activation of
caspase-8
and the release of cytochrome c from mitochondria. When administered in vivo, the two kynurenines caused depletion of specific thymocyte subsets in a fashion qualitatively similar to dexamethasone. These data suggest that the selective deletion of T lymphocytes may be a major mechanism whereby tryptophan metabolism affects immunity under physiopathologic conditions.
...
PMID:T cell apoptosis by tryptophan catabolism. 1223 95
Exposure of renal tubular epithelial cells (TEC) to IFN-gamma/TNF-alpha leads to Fas/FasL-mediated self-injury, which contributes to allograft rejection.
Indoleamine 2,3-dioxygenase
(
IDO
) converts tryptophan to N-formyl-kynurenine and contributes to immune privilege in tissues by increasing Fas-mediated T cell apoptosis. However, renal expression of
IDO
and its role in promoting Fas-mediated TEC death have not been examined.
IDO
expression was analyzed by RT-PCR and Western blot. Apoptosis was measured by fluorescence-activated cell sorting analysis and terminal deoxytransferase-mediated dUTP nick end labeling. We demonstrated that functional
IDO
is expressed in TEC and is increased by IFN-gamma/TNF-alpha exposure. Increased
IDO
activity promoted TEC apoptosis, whereas inhibition of
IDO
by its specific inhibitor 1-methyl-d-tryptophan attenuated IFN-gamma/TNF-alpha-mediated TEC apoptosis and augmented TEC survival. Transgenic expression of
IDO
resulted in increased TEC apoptosis in the absence of proinflammatory cytokine exposure, supporting a central role for
IDO
in TEC injury. Inhibition of
IDO
-mediated TEC death by a
caspase-8
-specific inhibitor (Z-IETD-FMK), as well as the absence of an
IDO
effect in Fas-deficient and FasL-deficient TEC, supports a Fas/FasL-dependent,
caspase-8
-mediated mechanism for
IDO
-enhanced TEC death. These data suggest that renal
IDO
expression may be deleterious during renal inflammation, because it enhances TEC self-injury through Fas/FasL interactions. Thus attenuation of
IDO
may represent a novel strategy to promote kidney function following ischemia and renal allograft rejection.
...
PMID:Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells. 1760 91